Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Andrew John Phillips currently holds 22,195 shares of Enliven Therapeutics, Inc. (ELVN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew John Phillips has been a net neutral trader of ELVN stock. They have purchased $0 and sold $0 worth of shares.
Andrew John Phillips's most recent insider trade was on Jun 17, 2026, when they sold 22,195 shares at $0.00 per share.
Andrew John Phillips serves as Executive at Enliven Therapeutics, Inc. (ELVN). They have executed 6 insider transactions totaling $0 over their tenure at the company.
Andrew John Phillips holds the position of Executive at Enliven Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Andrew John Phillips has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Andrew John Phillips was on Jun 17, 2026, when they purchased $0 worth of MLTX shares. This transaction involved 22,195 shares at N/A per share.
Andrew John Phillips currently owns 22,195 shares of Enliven Therapeutics, Inc. (ELVN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Andrew John Phillips's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Andrew John Phillips has 6 Form 4 filings on record as an insider at Enliven Therapeutics, Inc..
Set alerts for Andrew John Phillips and 40,000+ other insiders.